Details of the Drug
General Information of Drug (ID: DM2KXFS)
Drug Name |
3-[(1s)-1-(Dimethylamino)Ethyl]Phenol
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
139306-10-8; (S)-3-(1-(dimethylamino)ethyl)phenol; 3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL; 3-[(1S)-1-(Dimethylaminoethyl)]phenol; (s)-3-[1-(dimethylamino)ethyl]phenol; 3-((S)-1-Dimethylamino-ethyl)-phenol; UNII-1608PLR9ZO; (S)-3-1(-Dimethylamino)ethylphenol; NAP-226-90; (S)-3-1(- Dimethylamino)ethylphenol; NAP 226-90; 1608PLR9ZO; (S)-3-(1-DIMETHYLAMINOETHYL)PHENOL; Phenol, 3-[(1S)-1-(dimethylamino)ethyl]-; AK-51758; 3-((1S)-1-(Dimethylamino)ethyl)phenol; Phenol, 3-((1S)-1-(dimethylamino)ethyl)-; SAF; A1-00312; W-205531
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 165.23 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 1.8 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||